Recursion Pharmaceuticals (RXRX) has been drawing attention after recent trading, with the stock closing at $4.67. Investors are weighing this price against the company’s clinical pipeline and ongoing ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best debt-free penny stocks to buy right now. On December 17, JPMorgan upgraded Recursion Pharmaceuticals (NASDAQ:RXRX) to an Overweight ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

1. Long-Context Reasoning: Recursive language models (RLMs) now enable reasoning over effectively unlimited context, ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Artificial intelligence is moving beyond standalone large language model wrappers toward collections of specialized AI agents that reason, act, ...

On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation. “GPT-5.3-Codex is our first model that was instrumental in creating itself,” ...

The go-to-market AI sector has become one of the most crowded verticals in enterprise software. Companies like Gong and Clari now compete alongside dozens of well-funded startups, all pursuing the ...

The frontier AI labs continue releasing models that are better than their predecessors, but there’s an interesting change in how they operate ...

My top favorite algorithm is a "simple" one. I learned it in college; which went into exhausting details using fractions to show how much data it contains. I'll skip that part of the description.

Ricursive Intelligence, a frontier AI lab founded by the co-creators of AlphaChip, today announced a $300 million Series A funding round led by Lightspeed Venture Partners at a $4 billion post-money ...